Fubotv earnings beat by $0.10, revenue topped estimates
On Monday, Marex Group PLC (NASDAQ: MRX) had its price target increased by Jefferies from $38.00 to $42.00. The firm sustained its Buy rating on the stock. Currently trading at $36.38, Marex is fairly valued according to InvestingPro analysis. The adjustment comes after Marex reported its fourth-quarter results for 2024. Jefferies analyst Daniel Fannon has kept the first-quarter 2025 earnings per share (EPS) estimate steady at $0.83, while the full-year 2025 EPS forecast has been revised upward from $3.00 to $3.11.
The revised estimates by Jefferies reflect a positive shift in Marex’s operations, including heightened activity levels, growing client balances, and better yields on those balances. The company’s strong performance is evidenced by its impressive 93.6% price return over the past year and 16.7% gain year-to-date. According to Fannon’s observations, the beginning of the first quarter of 2025 has shown a promising volume environment. This trend is notably more robust than what was seen in the last quarter of 2024, as indicated by the volumes reported by listed exchanges.
Jefferies’ updated stance on Marex is based on the company’s recent performance and the early indicators from the current quarter. The firm’s analysis suggests that Marex is experiencing a favorable period of business, with client engagement and market participation contributing to the optimistic outlook. InvestingPro data shows the company maintains a "GREAT" overall Financial Health Score of 3.15 out of 5, with particularly strong growth metrics.
Marex’s financial health and market position appear to be solid, as evidenced by the company’s ability to maintain stable earnings while expanding its client base and capitalizing on increased market activity. The company’s P/E ratio of 13.3 and revenue growth of 25.2% in the last twelve months demonstrate its strong market position. Discover more insights about Marex and 1,400+ other stocks with InvestingPro’s comprehensive research reports. The positive adjustment of the price target by Jefferies signals confidence in Marex’s continued growth and its ability to leverage market conditions to its advantage.
Investors may view the revised price target and sustained Buy rating as a sign of Marex’s potential for sustained financial performance and market success throughout the year. As the company navigates the first quarter of 2025, market watchers will be attentive to any further developments that could influence Marex’s trajectory and valuation.
In other recent news, Marex Group PLC has reported strong financial results, with adjusted earnings per share exceeding expectations by $0.12 due to higher revenues and non-operating income. Keefe, Bruyette & Woods maintained an Outperform rating with a $36 price target, emphasizing the company’s revenue outperformance and robust start to 2025. Citi analyst Chris Allen raised the price target for Marex Group shares to $45, maintaining a Buy rating, citing the company’s strong fourth-quarter performance and market share gains. The firm anticipates further growth through product and geographical expansion, with upcoming acquisitions of Aarna Capital and Hamilton Court seen as pivotal steps.
Despite these positive developments, HSBC analysts downgraded Marex’s stock from Buy to Hold, though they increased the price target to $36. The downgrade reflects a view that the current valuation already captures the company’s success, and further growth would need to be significant and sustainable. Citi projects that Marex Group could surpass its adjusted operating profit guidance for 2024, with an expected $310 million against the set guidance of $300-305 million. The company’s leverage in the energy and commodities sectors and regional expansion are highlighted as key factors for continued success. These developments underscore Marex Group’s dynamic positioning and strategic growth initiatives in the market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.